Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana

被引:23
|
作者
Biritwum, Nana-Kwadwo [1 ]
Garshong, Bertha [2 ]
Alomatu, Bright [1 ]
de Souza, Dziedzom K. [3 ]
Gyapong, Margaret [4 ]
Kyelem, Dominique [5 ]
机构
[1] Ghana Hlth Serv, Neglected Trop Dis Program, Accra, Ghana
[2] Ghana Hlth Serv, Res & Dev Div, Accra, Ghana
[3] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana
[4] Dodowa Hlth Res Ctr, Dodowa, Ghana
[5] Taskforce Global Hlth, Decatur, GA USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2017年 / 11卷 / 05期
关键词
QUALITY IMPROVEMENT; GLOBAL PROGRAM; INDIA; HEALTH; IVERMECTIN; MANAGEMENT; COMMUNITY; COVERAGE; ORISSA; ROUNDS;
D O I
10.1371/journal.pntd.0005619
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Global Program to Eliminate Lymphatic Filariasis (GPELF) advocates for the treatment of entire endemic communities, in order to achieve its elimination targets. LF is predominantly a rural disease, and achieving the required treatment coverage in these areas is much easier compared to urban areas that are more complex. In Ghana, parts of the Greater Accra Region with Accra as the capital city are also endemic for LF. Mass Drug Administration (MDA) in Accra started in 2006. However, after four years of treatment, the coverage has always been far below the 65% epidemiologic coverage for interrupting transmission. As such, there was a need to identify the reasons for poor treatment coverage and design specific strategies to improve the delivery of MDA. This study therefore set out to identify the opportunities and barriers for implementing MDA in urban settings, and to develop appropriate strategies for MDA in these settings. An experimental, exploratory study was undertaken in three districts in the Greater Accra region. The study identified various types of non-rural settings, the social structures, stakeholders and resources that could be employed for MDA. Qualitative assessment such as in-depth interviews (IDIs) and focus group discussions (FGDs) with community leaders, community members, health providers, NGOs and other stakeholders in the community was undertaken. The study was carried out in three phases: pre-intervention, intervention and post-intervention phases, to assess the profile of the urban areas and identify reasons for poor treatment coverage using both qualitative and quantitative research methods. The outcomes from the study revealed that, knowledge, attitudes and practices of community members to MDA improved slightly from the pre-intervention phase to the post-intervention phase, in the districts where the interventions were readily implemented by health workers. Many factors such as adequate leadership, funding, planning and community involvement, were identified as being important in improving implementation and coverage of MDA in the study districts. Implementing MDA in urban areas therefore needs to be given significant consideration and planning, if the required coverage rates are to be achieved. This paper, presents the recommendations and strategies for undertaking MDA in urban areas.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?
    Koudou, Benjamin G.
    de Souza, Dziedzom K.
    Biritwum, Nana-Kwadwo
    Bougma, Roland
    Aboulaye, Meite
    Elhassan, Elizabeth
    Bush, Simon
    Molyneux, David H.
    [J]. LANCET INFECTIOUS DISEASES, 2018, 18 (06): : E214 - E220
  • [2] Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India
    Ramaiah, KD
    Kumar, KNV
    Chandrakala, AV
    Augustin, DJ
    Appavoo, NC
    Das, PK
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (12) : 1062 - 1069
  • [3] Elimination of lymphatic filariasis in Loa loa areas
    Montresor, Antonio
    King, Jonathan D.
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (07): : 683 - 684
  • [4] Strategies and tools for the control/elimination of lymphatic filariasis
    Ottesen, EA
    Duke, BOL
    Karam, M
    Behbehani, K
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1997, 75 (06) : 491 - 503
  • [5] Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana
    Adams, Nathaniel N. K.
    Ahorlu, Collins S.
    de Souza, Dziedzom K.
    Aikins, Moses
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (05):
  • [6] Alternative drug regimens and mass drug administration strategies for lymphatic filariasis and onchocerciasis elimination programmes
    Weil, G. J.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 28 - 28
  • [7] Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission
    Gbakima, AA
    Appawu, MA
    Dadzie, S
    Karikari, C
    Sackey, SO
    Baffoe-Wilmot, A
    Gyapong, J
    Scott, AL
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2005, 10 (04) : 387 - 392
  • [8] A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery
    Weil, Gary J.
    Jacobson, Julie A.
    King, Jonathan D.
    [J]. INTERNATIONAL HEALTH, 2021, 13 : S60 - S64
  • [9] LESSONS FROM MASS DRUG ADMINISTRATION FOR THE ELIMINATION OF LYMPHATIC FILARIASIS (LF) IN AN URBAN SETTING IN HAITI
    Bennett, Cudjoe
    Fayette, Carl
    Monestime, Franck
    Javel, Alain
    Miller, Lior
    Craciunoiu, Sarah
    Direny, Abdel
    Lemoine, Jean-Franze
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 155 - 155
  • [10] Using intervention mapping to design and implement quality improvement strategies towards elimination of lymphatic filariasis in Northern Ghana
    Manyeh, Alfred Kwesi
    Ibisomi, Latifat
    Baiden, Frank
    Chirwa, Tobias
    Ramaswamy, Rohit
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (03):